Your browser doesn't support javascript.
loading
Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer.
Federico, L; McGrail, D J; Bentebibel, S-E; Haymaker, C; Ravelli, A; Forget, M-A; Karpinets, T; Jiang, P; Reuben, A; Negrao, M V; Li, J; Khairullah, R; Zhang, J; Weissferdt, A; Vaporciyan, A A; Antonoff, M B; Walsh, G; Lin, S-Y; Futreal, A; Wistuba, I; Roth, J; Byers, L A; Gaudreau, P-O; Uraoka, N; Cruz, A F; Dejima, H; Lazcano, R N; Solis, L M; Parra, E R; Lee, J J; Swisher, S; Cascone, T; Heymach, J V; Zhang, J; Sepesi, B; Gibbons, D L; Bernatchez, C.
Affiliation
  • Federico L; Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • McGrail DJ; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Bentebibel SE; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Haymaker C; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Ravelli A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Forget MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Karpinets T; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Jiang P; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Reuben A; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Negrao MV; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Li J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Khairullah R; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Weissferdt A; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Vaporciyan AA; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Antonoff MB; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Walsh G; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Lin SY; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Futreal A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Wistuba I; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Roth J; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Byers LA; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Gaudreau PO; Department of Oncology, Queens' University and the Canadian Cancer Trials Group, Kingston, Canada.
  • Uraoka N; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Cruz AF; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Dejima H; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Lazcano RN; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Solis LM; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Parra ER; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Lee JJ; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Swisher S; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Cascone T; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Heymach JV; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: jzhang20@mdanderson.org.
  • Sepesi B; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: bsepesi@mdanderson.org.
  • Gibbons DL; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: dlgibbon@mdanderson.org.
  • Bernatchez C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: cbernatchez@mdanderson.org.
Ann Oncol ; 33(1): 42-56, 2022 01.
Article in En | MEDLINE | ID: mdl-34653632

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: United States